Insider Cluster (2 insiders) ·Filed Jul 3, 2026

WRBY

Warby Parker Inc.
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $1.8M total
Actionable Insight • Neutral

Insider sales at this scale do not convey material negative information. Monitor next quarterly filing (Q2 2026) for any operational guidance shifts; these sales appear to be routine executive compensation diversification, not a signal of deteriorating fundamentals. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
WRBY ▼ -15.72% at T+60d
NEUTRAL call ✗ call lost -15.72% · α vs SPY -19.29% · entry $29.26 → $24.66
Entry anchored
Jul 2, 03:59 PM ET
via exchange tick
T+1d
-0.14%
call -0.14% · α -1.01%
$29.22
settled 3mo ago
T+5d
+0.21%
call +0.21% · α -0.73%
$29.32
settled 3mo ago
T+20d
-11.07%
call -11.07% · α -10.66%
$26.02
settled 2mo ago
T+60d
-15.72%
call -15.72% · α -19.29%
$24.66
settled 4d ago

Price Chart

Loading chart...

Executive Summary

Two Warby Parker insiders — Co-CEO Neil Blumenthal and Director Jeffrey Raider — sold a combined $1.76M in open-market stock within a week. The Co-CEO also exercised zero-cost options (non-cash), typical of planned equity vesting. At $3.6B market cap, these sales represent ~0.05% of float, well below materiality thresholds, suggesting routine liquidity/portfolio diversification rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$1.8M
Insiders
2

Key Facts

  • Co-CEO Neil Blumenthal sold 36,300 shares at $30.04 on June 29 for $1.09M
  • Director Jeffrey Raider sold 22,500 shares at $29.72 on July 1 for $669K
  • Blumenthal also exercised 72,600 stock-settled derivative units at $0 (non-cash, no economic value)
  • Total cluster open-market sales: $1.76M, or ~0.05% of $3.6B market cap
  • No insider purchases recorded in the cluster window

Financial Impact

$1.76M in open-market sales, trivial relative to $3.6B market cap (0.05%)

dilution

Risk Factors

  • Co-CEO selling near the high may indicate personal bearishness, but dollar amount is too small to move stock
  • If Q2 2026 results disappoint, these sales could be viewed unfavorably in hindsight

Market Snapshot

Exchange
NYSE
Sector
Ophthalmic Goods
Analyst Consensus
70% bullish (20 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-WRBY-1783037436535
9 reports for WRBY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for WRBY — sortable, filterable
TypeNow
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$29.32 $26.96▼ −8.05%▼ −10.29%$27.78 (−5.25%)
Jul 3, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$29.26 $26.02▼ −11.07%▼ −10.66%$27.78 (−5.06%)
Jun 14, 2026
15w ago
Institutional Cluster
MIXED ★ 4/10
$26.38 $27.41▲ +3.90%▲ +4.65%$27.78 (+5.31%)
Jun 12, 2026
15w ago
144
NEUTRAL ★ 2/10
$26.38 $27.41▲ +3.90%▲ +4.65%$27.78 (+5.31%)
Jun 11, 2026
16w ago
Institutional Cluster
MIXED ★ 4/10
$25.86 $29.32▲ +13.38%▲ +11.49%$27.78 (+7.42%)
May 21, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$25.09 $26.12▲ +4.11%▲ +5.52%$27.78 (+10.72%)
May 13, 2026
20w ago
144
NEUTRAL ★ 3/10
$28.90 $26.46▼ −8.44%▼ −7.58%$27.78 (−3.88%)
Mar 4, 2026
30w ago
Insider Cluster
NEUTRAL ★ 4/10
$27.36 $21.41▼ −21.75%▼ −17.33%$27.78 (+1.54%)
Feb 26, 2026
31w ago
8-K
BULLISH ★ 8/10
$25.65 $21.99▼ −14.27%▼ −7.87%$27.78 (+8.30%)
Showing 9 of 9

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 3, 2026